To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.



Centre Plaza Postal Outlet
128 Queen Street South PO Box 42257
Ontario, L5M 4Z0 Canada





800 Number


Email Address

[email protected]


GADA CANADA is an international, non-profit organization dedicated to preventing disabling symptoms and life-threatening complications of Marfan syndrome and improving the quality of life for people affected by this disorder. Marfan syndrome is a rare inherited connective tissue disorder characterized by abnormalities of the heart and blood vessels (cardiovascular system), skeleton, and eyes. Affected individuals may be unusually tall and thin, have abnormally large hands and feet, have malformations of the chest and spine, and experience weakness of the joints, ligaments, and tendons. The Canadian Marfan Association is dedicated to increasing public awareness of Marfan syndrome in Canada by holding public information meetings, community support group meetings, and media interviews; to providing accurate, timely information about the disorder to affected individuals, families, and physicians; assisting people with Marfan syndrome and their families with quality of life issues and helping them form self-help groups; and to acting as a communication liaison for people with Marfan syndrome with the community. The association also seeks to support and foster research in the area of connective tissue diseases.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.